Functional Implications of Biochemical and Molecular Characteristics of Donation After Circulatory Death Livers

Ryota Masuzaki1, Hui Yu2, Philip Kingsley3

  • 1The Transplant Center, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN.

Transplantation Direct
|August 9, 2016
PubMed

Insights

Lower adenosine triphosphate (ATP) levels in livers from circulatory death donors (DCD) immediately after cold perfusion correlate with ischemic injury. Gene expression changes in DCD livers may offer insights for improving transplant outcomes.

Area of Science:

  • Transplantation immunology
  • Organ preservation
  • Biochemistry

Background:

  • Livers from donors after circulatory death (DCD) have lower graft and patient survival rates than those from brain dead donors (DBD).
  • A method to predict DCD liver function is needed to improve organ utilization and patient outcomes.
  • Ischemic time in DCD donors may cause immediate biochemical and molecular changes affecting graft function.

Purpose of the Study:

  • To identify biochemical and molecular markers in DCD livers that predict post-transplant function.
  • To investigate the impact of ischemic time on DCD liver viability.
  • To compare DCD and DBD liver tissue immediately after cold perfusion and during cold storage.

Main Methods:

  • Biopsies of DCD and DBD livers were analyzed immediately after cold perfusion and during cold storage.
  • Biochemical analysis included adenosine triphosphate (ATP) and other metabolites.
  • Molecular analysis involved transcriptional profiling using high-throughput sequencing.
  • Metabolite levels were correlated with post-transplant aspartate aminotransferase (AST) levels.

Main Results:

  • DCD liver samples had significantly lower ATP and adenosine diphosphate (ADP) levels immediately post-perfusion compared to DBD samples.
  • Lower ATP levels correlated with higher peak AST levels in recipients, indicating greater ischemic injury.
  • 470 genes were differentially expressed in DCD livers, with upregulation in inflammation/immunity and downregulation in translation.
  • No significant transcriptional changes were observed during cold storage.

Conclusions:

  • ATP content post-perfusion is a reliable indicator of ischemic injury in DCD livers.
  • Transcriptional profiling reveals biological pathways relevant for enhancing DCD liver function.
  • Messenger RNA (mRNA) levels during cold storage are not prognostic due to transcriptional inactivity.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
650
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
313